To test this, we examined the effect of conditioned medium (CM) prepared from cultured mouse tumor-infiltrating CD8+ T cells, which were isolated from subcutaneous Hepa1-6 tumors treated with anti-PD1 therapy, on PRMT3 expression in cultured Hepa1-6 cells in vitro. This evidence concerns the gene CD8A and neoplasm.